X4 Pharmaceuticals

XFOR

Börsenwert 332 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Bain Capital Life Sciences Investors Boston, Massachusetts	10,6 Mio. $	–	–	–
2	2 NEA Management Company Timonium, Maryland	10,2 Mio. $	–	–	–
3	3 OrbiMed New York	5,06 Mio. $	–	–	–
4	4 Perceptive Advisors New York	3,95 Mio. $	+4,44 Mio. $	+151.515	Neu
5	5 Axa Paris, France	3,82 Mio. $	+34.041 $	+1.161	+0,8 %
6	6 Vanguard Group Malvern, Pennsylvania	3,78 Mio. $	+746.620 $	+25.464	+21 %
7	TLP 7 Tri Locum Partners New York	3,37 Mio. $	+168.066 $	+5.732	+5 %
8	8 Parkman Healthcare Partners Stamford, Connecticut	2,43 Mio. $	+412.042 $	+14.053	+18 %
9	9 Cormorant Asset Management Boston, Massachusetts	1,42 Mio. $	–	–	–
10	10 Geode Capital Management Boston, Massachusetts	964.555 $	+509.357 $	+17.372	+89 %
11	11 Millennium Management New York	940.000 $	-71.572 $	-2.441	-6 %
12	12 Schonfeld Strategic Advisors New York	902.190 $	+138.511 $	+4.724	+16 %
13	13 Lynwood Capital Management Toronto, Ontario, Canada	783.000 $	-1,23 Mio. $	-41.837	-58 %
14	GTC 14 Ghost Tree Capital New York	740.000 $	-146.603 $	-5.000	-15 %
15	SM 15 Scoggin Management New York	567.025 $	+473.821 $	+16.160	Neu
16	16 Point72 Asset Management Stamford, Connecticut	565.500 $	–	–	–
17	17 JP Morgan Chase New York	545.000 $	+494.961 $	+16.881	+423 %
18	18 Simplify Asset Management Las Vegas, Nevada	348.000 $	+390.932 $	+13.333	Neu
19	19 Ikarian Capital Dallas, Texas	303.745 $	–	–	–
20	20 BlackRock New York	298.914 $	+67.349 $	+2.297	+25 %
21	21 New Leaf Venture Partners New York	291.450 $	–	–	–
22	22 Susquehanna International Group Bala Cynwyd, Pennsylvania	245.816 $	+276.141 $	+9.418	Neu
23	23 Northern Trust Chicago, Illinois	195.289 $	+75.999 $	+2.592	+53 %
24	24 Bank of New York Mellon New York	148.938 $	–	–	–
25	25 State Street Boston, Massachusetts	148.451 $	–	–	–

X4 Pharmaceuticals XFOR Börsenwert 332 Mio. $

X4 Pharmaceuticals

XFOR

Börsenwert 332 Mio. $